Skip to Content

Posts tagged with "Academia (vs. Industry)"

  • Academia (vs. Industry)

    Decline of the Midwest?

    Here’s an article at The Atlantic (via the Washington Monthly) that should concern anyone involved in R&D. It’s about the funding problems of many of the large public universities, particularly in the Midwest. Chemists will recognize several historically strong departments in that part of the country – but may also have noted… Read More
  • Academia (vs. Industry)

    Allow Me to Peruse Your Grant

    This is one that I certainly hadn’t heard of until a few days ago. According to this article, academic scientists are using the Freedom of Information Act (FOIA) to get a look at other people’s grant applications. In the past few years, some scientists have complained that FOIA has been weaponized by activists and special interest gro… Read More
  • Academia (vs. Industry)

    Changes in NIH Grant Policy?

    There are some pretty big funding changes being proposed at the NIH that many people may not be aware of. A concerned NIH grantee has sent along some links and comments about these, and I think that they’re worth bringing up. Here’s a blog post by Mike Lauer of the NIH going into some details: Read More
  • Academia (vs. Industry)

    A Call For Academic Drug Companies

    An editorial in Cell asks “How Much Longer Will We Put Up With $100,000 Cancer Drugs?” I’m of two minds on questions like that. OK, three minds. The immediate impulse, not an honorable one, is to respond with pure snark, which is always tempting, in the vein of “If you can keep your company going… Read More
  • Academia (vs. Industry)

    From Industry Into Teaching?

    An email from a former colleague brought up a topic that I don’t think has been addressed here before directly: what experiences do readers have as industrial scientists who have then moved into teaching positions? I know that this is a fairly frequent move. For the readership here, I’d guess that many of the examples… Read More
  • Academia (vs. Industry)

    Vanderbilt Heads Into the Clinic for Alzheimer’s

    There’s an interesting experiment underway at Vanderbilt, where a team from the university is taking a possible Alzheimer’s candidate into clinical trials on their own. Now, you could come up with several headlines for this, along the lines of “Academic researchers in way over their heads”, or “Plucky professors make e… Read More
  • Academia (vs. Industry)

    Come, Let Us Reason Together

    Here’s an editorial from Morris Birnbaum of Pfizer on collaboration between academia and the drug industry. He’s worked on both sides of the fence, so that makes for some useful comparisons. I think the summary sentence would be this one: “It seems obvious that many of the obstacles to effective academic-pharmaceutical partnership… Read More
  • Academia (vs. Industry)

    A Lament From the Treadmill

    Here’s neuroscientist Mark Humphries on the recent release by the Allen Institute of a huge pile of data on visual cortex processing. The “Allen Brain Observatory” details the activity of neurons in the mouse brain in response to a range of different visual cues. It’s broken down by layers of the cortex and by known… Read More
  • Academia (vs. Industry)

    Want Your Compounds Tested Against Pathogens For Free?

    I’d like to help publicize what seems like a very worthwhile effort, funded by the University of Queensland and the Wellcome Trust: the Community for Open Antimicrobial Drug Discovery (CO-ADD). Here’s a writeup on them in Nature – what they’re doing is taking compounds from all sources and screening them against panels of i… Read More
  • Academia (vs. Industry)

    A Professor’s View On Drug Company Collaborations

    My post the other day on Phil Baran’s public-private funding ideas brought in a lot of comment. As usual, I encourage a look a the comments section if you’re interested in the topic, or any topic that comes up around here – a lot of people who know whereof they speak show up. But I… Read More
123...